Close Menu

NEW YORK (GenomeWeb) – Akonni Biosystems announced today it has been awarded a three-year, $3 million Small Business Innovation Research grant from the National Institutes of Health.

Akonni said it will use the funding to accelerate commercialization of an assay for extensively drug-resistant tuberculosis and simultaneous drug susceptibility testing called TruArray that uses on-slide PCR within a microarray chamber. The company will also further develop the assay on its fully integrated point-of-care molecular diagnostics platform, the TruDx 3000. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.